Conning Inc. Becton Dickinson & CO Transaction History

Conning Inc.

$2.8 Billion
Q3 2025

A detailed history of Conning Inc. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Conning Inc. holds 1,829 shares of BDX stock, worth $353,070. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,829

Previous 1,829 -0.0%

Holding current value

$353,070

Previous $315,000 8.57%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 24, 2025	SELL	$165.15 - $226.42 $16,515 - $22,642	-100 Reduced 5.18%	1,829 $315,000
Q4 2024 Jan 28, 2025	SELL	$220.02 - $243.75 $6,160 - $6,825	-28 Reduced 1.43%	1,929 $437,000
Q3 2024 Oct 29, 2024	SELL	$221.47 - $242.41 $1,107 - $1,212	-5 Reduced 0.25%	1,957 $471,000
Q2 2024 Jul 26, 2024	BUY	$225.07 - $246.17 $11,253 - $12,308	50 Added 2.62%	1,962 $458,000
Q1 2024 Apr 26, 2024	SELL	$233.45 - $247.73 $11,672 - $12,386	-50 Reduced 2.55%	1,912 $473,000
Q4 2023 Jan 29, 2024	BUY	$232.24 - $267.23 $2,322 - $2,672	10 Added 0.51%	1,962 $478,000
Q3 2023 Oct 26, 2023	SELL	$254.9 - $283.59 $7,647 - $8,507	-30 Reduced 1.51%	1,952 $504,000
Q2 2023 Jul 21, 2023	SELL	$238.39 - $265.32 $77,476 - $86,229	-325 Reduced 14.09%	1,982 $523,000
Q1 2023 Apr 27, 2023	SELL	$229.71 - $259.35 $7.27 Million - $8.21 Million	-31,663 Reduced 93.21%	2,307 $571,000
Q4 2022 Feb 07, 2023	BUY	$218.29 - $256.91 $6.84 Million - $8.05 Million	31,320 Added 1181.89%	33,970 $8.64 Million
Q3 2022 Oct 28, 2022	SELL	$51.03 - $264.23 $13,829 - $71,606	-271 Reduced 9.28%	2,650 $590,000
Q2 2022 Jul 20, 2022	SELL	$234.74 - $275.42 $7,276 - $8,538	-31 Reduced 1.05%	2,921 $720,000
Q1 2022 May 02, 2022	BUY	$243.64 - $270.48 $34,109 - $37,867	140 Added 4.98%	2,952 $785,000
Q4 2021 Jan 27, 2022	SELL	$230.08 - $250.94 $177,621 - $193,725	-772 Reduced 21.54%	2,812 $707,000
Q3 2021 Nov 05, 2021	BUY	$232.72 - $256.47 $65,394 - $72,068	281 Added 8.51%	3,584 $881,000
Q2 2021 Jul 29, 2021	SELL	$232.65 - $254.58 $121,210 - $132,636	-521 Reduced 13.62%	3,303 $803,000
Q1 2021 Apr 23, 2021	SELL	$232.09 - $256.88 $84,712 - $93,761	-365 Reduced 8.71%	3,824 $930,000
Q4 2020 Jan 28, 2021	SELL	$221.92 - $245.94 $5,769 - $6,394	-26 Reduced 0.62%	4,189 $1.05 Million
Q3 2020 Oct 21, 2020	BUY	$215.77 - $276.76 $15,103 - $19,373	70 Added 1.69%	4,215 $981,000
Q2 2020 Aug 07, 2020	BUY	$219.9 - $263.41 $31,885 - $38,194	145 Added 3.62%	4,145 $992,000
Q1 2020 Apr 29, 2020	SELL	$195.69 - $279.01 $149,702 - $213,442	-765 Reduced 16.05%	4,000 $919,000
Q4 2019 Jan 29, 2020	SELL	$236.45 - $266.82 $33,103 - $37,354	-140 Reduced 2.85%	4,765 $1.3 Million
Q3 2019 Oct 30, 2019	SELL	$230.58 - $256.08 $41,273 - $45,838	-179 Reduced 3.52%	4,905 $1.24 Million
Q2 2019 Jul 25, 2019	SELL	$217.4 - $246.08 $364,797 - $412,922	-1,678 Reduced 24.82%	5,084 $1.28 Million
Q1 2019 Apr 22, 2019	BUY	$206.05 - $248.17 $8,242 - $9,926	40 Added 0.6%	6,762 $1.69 Million
Q4 2018 Jan 29, 2019	SELL	$204.73 - $257.93 $193,265 - $243,485	-944 Reduced 12.31%	6,722 $1.52 Million
Q3 2018 Oct 26, 2018	SELL	$233.07 - $256.0 $116,301 - $127,744	-499 Reduced 6.11%	7,666 $2 Million
Q2 2018 Jul 25, 2018	SELL	$208.1 - $233.85 $20,810 - $23,385	-100 Reduced 1.21%	8,165 $1.96 Million
Q1 2018 May 04, 2018	BUY	$205.46 - $240.27 $429,000 - $501,683	2,088 Added 33.8%	8,265 $1.79 Million
Q4 2017 Jan 30, 2018	SELL	$189.0 - $222.64 $13,230 - $15,584	-70 Reduced 1.12%	6,177 $1.32 Million
Q3 2017 Oct 20, 2017	BUY	$186.89 - $198.9 $1.17 Million - $1.24 Million	6,247	6,247 $1.22 Million

Others Institutions Holding BDX

# of Institutions

1,731

Shares Held

262M

Call Options Held

1.41M

Put Options Held

618K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $55.1B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.

Account